Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Alimentary Pharmacology & Therapeutics|December 5, 2008
Psychopathology is associated with dyspeptic symptom severity in primary care patients with a new episode of dyspepsiaS Mujakovic, N J de Wit, C J van Marrewijk, et al.
BMC Public Health|August 7, 2024
Citizens' perspectives on healthy weight approaches in low SEP neighborhoods: a qualitative study from a systems perspectiveMaud J J Ter Bogt, Yentl Z Te Riele, Piet G C Kooijman, et al.
Arthritis Care & Research|January 28, 2015
Effect of Aerobic Exercise Training on Fatigue in Rheumatoid Arthritis: A Meta-AnalysisS A A Rongen-van Dartel, H Repping-Wuts, M Flendrie, et al.
Lancet (London, England)|January 20, 2009
Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trialCorine J van Marrewijk, Suhreta Mujakovic, Gerdine A J Fransen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 18, 2014
An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factorsP P M van Lümig, S P Menting, J M P A van den Reek, et al.
Annals of the Rheumatic Diseases|July 16, 2008
Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months: clinical effectiveness and costs of observed care and different alternative strategiesW Kievit, J Fransen, E M Adang, et al.
Annals of the Rheumatic Diseases|November 18, 2010
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research GroupJ Avouac, J Fransen, U A Walker, et al.
Annals of the Rheumatic Diseases|April 4, 2008
The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritisE J M Toonen, M J H Coenen, W Kievit, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2009
Influence of gastric mucosal status on success of stepwise acid suppressive therapy for dyspepsiaC J van Marrewijk, M G H van Oijen, L I Paloheimo, et al.
Annals of the Rheumatic Diseases|January 5, 2008
The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice dataW Kievit, E M Adang, J Fransen, et al.
Pageof 14